Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

California votes for embryonic stem cell research

Nature Biotechnology volume 22, pages 1485–1486 (2004)Cite this article

$3 billion over 10 years will be devoted to stem cell research.

However, post-election celebrating linger several sets of concerns. Some have to do with how well the proposed California Institute for Regenerative Medicine will regulate and fund human stem cell and related research activities. Because the source of the funds is not federal, research involving the creation of new ES cell lines would not be hampered by the restrictions imposed by President George W. Bush on August 9, 2001, limiting research to a set of cells lines established before that date (See Nat. Biotechnol. 19, 791, 2001)

Your institute does not have access to this article

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

Author information

Authors and Affiliations

  1. Washington

    Jeffrey L. Fox

Authors
  1. Jeffrey L. Fox
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related external links

Text of Proposition 71

Harvard University

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Fox, J. California votes for embryonic stem cell research. Nat Biotechnol 22, 1485–1486 (2004). https://doi.org/10.1038/nbt1204-1485

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1204-1485

Further reading

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing